Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2024 Filed Jun 12, 2024 20:38 UTC |
Yedid Robert A.Director
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020094 · rdgdoc.xml · nonDerivative · entry 1 Yedid Robert A. · CIK 0001792558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,490 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 23:16 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 3,902 | $1.30 | $5,072.60 |
DisclosureSEC source: 0001437749-24-010475 · rdgdoc.xml · nonDerivative · entry 1 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,695 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on March 28, 2024. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 23:13 UTC |
Cummings James F.Chief Medical Officer
|
Tax withholdingCommon Stock | 3,292 | $1.30 | $4,279.60 |
DisclosureSEC source: 0001437749-24-010473 · rdgdoc.xml · nonDerivative · entry 1 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,801 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on March 28, 2024. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:12 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-24-008753 · rdgdoc.xml · derivative · entry 5 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2034-03-17 F6 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:12 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-008753 · rdgdoc.xml · nonDerivative · entry 4 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,122 F5 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:10 UTC |
Lee Phillip EChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-24-008751 · rdgdoc.xml · derivative · entry 4 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2034-03-17 F5 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:10 UTC |
Lee Phillip EChief Financial Officer
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-008751 · rdgdoc.xml · nonDerivative · entry 3 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,808 F4 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:09 UTC |
Cummings James F.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-24-008750 · rdgdoc.xml · derivative · entry 4 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2034-03-17 F6 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:09 UTC |
Cummings James F.Chief Medical Officer
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-008750 · rdgdoc.xml · nonDerivative · entry 3 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,093 F5 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:07 UTC |
Berg Edward BSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-24-008749 · rdgdoc.xml · derivative · entry 4 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2034-03-17 F6 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:07 UTC |
Berg Edward BSVP, General Counsel
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-008749 · rdgdoc.xml · nonDerivative · entry 3 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,706 F5 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:03 UTC |
Lo StevenDirector · President, Chief Exec Officer
|
GrantStock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001437749-24-008748 · rdgdoc.xml · derivative · entry 2 Lo Steven · CIK 0001501959 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2034-03-17 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:03 UTC |
Lo StevenDirector · President, Chief Exec Officer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-008748 · rdgdoc.xml · nonDerivative · entry 1 Lo Steven · CIK 0001501959 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 F1 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| February 02, 2024 Filed Mar 21, 2024 00:12 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 9,220 | $1.20 | $11,064.00 |
DisclosureSEC source: 0001437749-24-008753 · rdgdoc.xml · nonDerivative · entry 3 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,122 F1 · date: This transaction is being reported late due to administrative oversight. F4 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2024. Read SEC document |
| February 02, 2024 Filed Mar 21, 2024 00:09 UTC |
Cummings James F.Chief Medical Officer
|
Tax withholdingCommon Stock | 7,965 | $1.20 | $9,558.00 |
DisclosureSEC source: 0001437749-24-008750 · rdgdoc.xml · nonDerivative · entry 2 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,093 F1 · date: This transaction is being reported late due to administrative oversight. F4 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2024. Read SEC document |
| February 02, 2024 Filed Mar 21, 2024 00:07 UTC |
Berg Edward BSVP, General Counsel
|
Tax withholdingCommon Stock | 9,220 | $1.20 | $11,064.00 |
DisclosureSEC source: 0001437749-24-008749 · rdgdoc.xml · nonDerivative · entry 2 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,706 F1 · date: This transaction is being reported late due to administrative oversight. F4 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2024. Read SEC document |
| December 15, 2023 Filed Mar 21, 2024 00:10 UTC |
Lee Phillip EChief Financial Officer
|
Tax withholdingCommon Stock | 5,943 | $0.63 | $3,744.09 |
DisclosureSEC source: 0001437749-24-008751 · rdgdoc.xml · nonDerivative · entry 2 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,808 F1 · date: This transaction is being reported late due to administrative oversight. F3 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 15, 2023. Read SEC document |
| December 08, 2023 Filed Mar 21, 2024 00:12 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 34,288 | $0.71 | $24,344.48 |
DisclosureSEC source: 0001437749-24-008753 · rdgdoc.xml · nonDerivative · entry 2 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,342 F1 · date: This transaction is being reported late due to administrative oversight. F3 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023. Read SEC document |
| December 08, 2023 Filed Mar 21, 2024 00:10 UTC |
Lee Phillip EChief Financial Officer
|
Tax withholdingCommon Stock | 35,151 | $0.71 | $24,957.21 |
DisclosureSEC source: 0001437749-24-008751 · rdgdoc.xml · nonDerivative · entry 1 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,751 F1 · date: This transaction is being reported late due to administrative oversight. F2 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023. Read SEC document |
| December 08, 2023 Filed Mar 21, 2024 00:09 UTC |
Cummings James F.Chief Medical Officer
|
Tax withholdingCommon Stock | 31,409 | $0.71 | $22,300.39 |
DisclosureSEC source: 0001437749-24-008750 · rdgdoc.xml · nonDerivative · entry 1 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,058 F1 · date: This transaction is being reported late due to administrative oversight. F2 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023. F3 · balance_after: This amount includes 41,367 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan. Read SEC document |
| December 08, 2023 Filed Mar 21, 2024 00:07 UTC |
Berg Edward BSVP, General Counsel
|
Tax withholdingCommon Stock | 33,752 | $0.71 | $23,963.92 |
DisclosureSEC source: 0001437749-24-008749 · rdgdoc.xml · nonDerivative · entry 1 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,926 F1 · date: This transaction is being reported late due to administrative oversight. F2 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023. F3 · balance_after: This amount includes 36,072 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:23 UTC |
Watson W. MarkDirector
|
GrantStock Option (right to buy) · Derivative | 44,224 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001437749-23-021507 · rdgdoc.xml · derivative · entry 2 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,224 Underlying: Common Stock · 44,224 shares Expires 2033-06-26 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary of the date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:23 UTC |
Watson W. MarkDirector
|
GrantCommon Stock | 7,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021507 · rdgdoc.xml · nonDerivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,125 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:20 UTC |
HERON ELAINE JDirector
|
GrantStock Option (right to buy) · Derivative | 41,510 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001437749-23-021505 · rdgdoc.xml · derivative · entry 2 HERON ELAINE J · CIK 0001235471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,510 Underlying: Common Stock · 41,510 shares Expires 2033-06-26 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary of the date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:20 UTC |
HERON ELAINE JDirector
|
GrantCommon Stock | 6,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021505 · rdgdoc.xml · nonDerivative · entry 1 HERON ELAINE J · CIK 0001235471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,566 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:16 UTC |
Yedid Robert A.Director
|
GrantStock Option (right to buy) · Derivative | 44,224 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001437749-23-021503 · rdgdoc.xml · derivative · entry 2 Yedid Robert A. · CIK 0001792558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,224 Underlying: Common Stock · 44,224 shares Expires 2033-06-26 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary of the date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:16 UTC |
Yedid Robert A.Director
|
GrantCommon Stock | 7,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021503 · rdgdoc.xml · nonDerivative · entry 1 Yedid Robert A. · CIK 0001792558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,490 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:14 UTC |
Wheadon David E.Director
|
GrantStock Option (right to buy) · Derivative | 44,224 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001437749-23-021501 · rdgdoc.xml · derivative · entry 2 Wheadon David E. · CIK 0001789507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,224 Underlying: Common Stock · 44,224 shares Expires 2033-06-26 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary of the date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 01:14 UTC |
Wheadon David E.Director
|
GrantCommon Stock | 7,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021501 · rdgdoc.xml · nonDerivative · entry 1 Wheadon David E. · CIK 0001789507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,750 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 00:49 UTC |
Finney Michael J.Director
|
GrantStock Option (right to buy) · Derivative | 44,224 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001437749-23-021495 · rdgdoc.xml · derivative · entry 2 Finney Michael J. · CIK 0001650978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,224 Underlying: Common Stock · 44,224 shares Expires 2033-06-26 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary of the date of the grant. Read SEC document |
| June 26, 2023 Filed Aug 2, 2023 00:49 UTC |
Finney Michael J.Director
|
GrantCommon Stock | 7,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021495 · rdgdoc.xml · nonDerivative · entry 1 Finney Michael J. · CIK 0001650978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670,840 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2024 annual meeting of stockholders of the Issuer and June 26, 2024, the first anniversary date of the grant. Read SEC document |
| June 12, 2023 Filed Jun 15, 2023 01:02 UTC |
Lee Phillip EChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 102,500 | $0.00 Strike: $0.88 | $0.00 |
DisclosureSEC source: 0001437749-23-017474 · rdgdoc.xml · derivative · entry 2 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,500 Underlying: Common Stock · 102,500 shares Expires 2033-06-12 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on June 12, 2024, the first anniversary of the Start Date, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on June 12, 2027. Read SEC document |
| June 12, 2023 Filed Jun 15, 2023 01:02 UTC |
Lee Phillip EChief Financial Officer
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-017474 · rdgdoc.xml · nonDerivative · entry 1 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,902 F1 · shares: Grant of shares upon vesting of restricted stock units ("RSUs"). The RSUs vest as to 25% of the shares underlying the award on each anniversary of June 12, 2023 (the "Start Date"), so that the RSUs would be fully vested on the fourth anniversary of the Start Date. Read SEC document |
| March 28, 2023 Filed Mar 21, 2024 00:12 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 3,683 | $0.75 | $2,762.25 |
DisclosureSEC source: 0001437749-24-008753 · rdgdoc.xml · nonDerivative · entry 1 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,630 F1 · date: This transaction is being reported late due to administrative oversight. F2 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2023. Read SEC document |
| March 28, 2023 Filed Mar 21, 2025 01:43 UTC |
Cummings James F.Chief Medical Officer
|
Tax withholdingCommon Stock | 3,267 | $0.75 | $2,450.90 |
DisclosureSEC source: 0001437749-25-008653 · rdgdoc.xml · nonDerivative · entry 1 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,821 F1 · date: This transaction is being reported late due to administrative oversight. F2 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2023. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Floroiu Cezar AndreiDirector · President, Chief Exec Officer
|
GrantStock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001437749-23-007443 · rdgdoc.xml · derivative · entry 5 Floroiu Cezar Andrei · CIK 0001808794 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2033-03-16 F4 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on February 2, 2024, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on February 2, 2027. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Floroiu Cezar AndreiDirector · President, Chief Exec Officer
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001437749-23-007443 · rdgdoc.xml · derivative · entry 4 Floroiu Cezar Andrei · CIK 0001808794 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2033-03-16 F2 · derivative.exercise_date: The shares subject to this stock option shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Floroiu Cezar AndreiDirector · President, Chief Exec Officer
|
GrantCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007443 · rdgdoc.xml · nonDerivative · entry 3 Floroiu Cezar Andrei · CIK 0001808794 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,735 F3 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of February 2, 2023, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Floroiu Cezar AndreiDirector · President, Chief Exec Officer
|
GrantCommon Stock | 92,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007443 · rdgdoc.xml · nonDerivative · entry 2 Floroiu Cezar Andrei · CIK 0001808794 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,735 F1 · shares: Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Floroiu Cezar AndreiDirector · President, Chief Exec Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007443 · rdgdoc.xml · nonDerivative · entry 1 Floroiu Cezar Andrei · CIK 0001808794 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 F1 · shares: Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Berg Edward BSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001437749-23-007442 · rdgdoc.xml · derivative · entry 5 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2033-03-16 F4 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on February 2, 2024, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on February 2, 2027. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Berg Edward BSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 205,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001437749-23-007442 · rdgdoc.xml · derivative · entry 4 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2033-03-16 F2 · derivative.exercise_date: The shares subject to this stock option shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Berg Edward BSVP, General Counsel
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007442 · rdgdoc.xml · nonDerivative · entry 3 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,606 F3 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of February 2, 2023, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Berg Edward BSVP, General Counsel
|
GrantCommon Stock | 52,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007442 · rdgdoc.xml · nonDerivative · entry 2 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,606 F1 · shares: Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 22, 2023 00:06 UTC |
Berg Edward BSVP, General Counsel
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007442 · rdgdoc.xml · nonDerivative · entry 1 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 F1 · shares: Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 23:54 UTC |
Lee Phillip EChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 205,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001437749-23-007441 · rdgdoc.xml · derivative · entry 4 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2033-03-16 F2 · derivative.exercise_date: The shares subject to this stock option shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 23:54 UTC |
Lee Phillip EChief Financial Officer
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007441 · rdgdoc.xml · nonDerivative · entry 3 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,402 F3 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of February 2, 2023, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 23:54 UTC |
Lee Phillip EChief Financial Officer
|
GrantCommon Stock | 56,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007441 · rdgdoc.xml · nonDerivative · entry 2 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,402 F1 · shares: Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 23:54 UTC |
Lee Phillip EChief Financial Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007441 · rdgdoc.xml · nonDerivative · entry 1 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,750 F1 · shares: Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 23:54 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 410,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001437749-23-007440 · rdgdoc.xml · derivative · entry 7 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2033-03-16 F4 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on February 2, 2024, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on February 2, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.